medigraphic.com

2022, Número 2

<< Anterior Siguiente >>

Rev Cuba Endoc 2022; 33 (2)


Síndrome de ovario poliquístico y calidad de vida

Ovies CG, Monteagudo PG, Gómez AM

Idioma: Español
Referencias bibliográficas: 70
Paginas:
Archivo PDF: 214.87 Kb.


RESUMEN

Introducción: El síndrome de ovario poliquístico es la endocrinopatía más frecuente que afecta la mujer en la etapa reproductiva. Se ha investigado mucho en lo que concierne a su fisiopatología y criterios diagnósticos. Sin embargo, existen evidencias de que las mujeres que padecen el síndrome tienen mayor afectación en su calidad de vida. El tema ha sido poco abordado en general y en Cuba no existen estudios al respecto.
Objetivo: Identificar las evidencias científicas que amplíen el conocimiento acerca del efecto del síndrome de ovario poliquístico en la calidad de vida.
Métodos: Se realizó una revisión bibliográfica sobre la calidad de vida en mujeres con diagnóstico de síndrome de ovario poliquístico. La búsqueda se realizó en las bases de datos electrónicas Google Scholar, Pubmed Central y SCIELO Regional, a las cuales se accedió por medio del buscador web de Google. Se revisaron artículos completos, relacionados con estudios observacionales, prospectivos, artículos de revisión, revisiones sistemáticas y metaanálisis publicados fundamentalmente entre 2000 y 2020.
Conclusiones: La presente revisión pone en evidencia que el síndrome de ovario poliquístico es una condición que por la variedad de manifestaciones clínicas que lo caracterizan conlleva a un deterioro de la calidad de vida de las mujeres que la padecen.
Una intervención terapéutica en cada una de ellas resulta beneficiosa para elevar el bienestar físico y psicológico y como resultado de la calidad de vida.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Stein I, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935 [acceso 13/10/2020];29:181-91. Disponible en: https://scholar.google.com/scholar_lookup?journal=Am+J+Obstet+Gynecol&title=Ame norrhea+associated+with+bilateral+polycystic+ovaries&author=IF+Stein&author=ML+Leventhal&volume=29&publication_year=1935&pages=181-191&

  2. Smith KD, Se PW. Polycystic ovarian disease (PCO). A report of 301 cases. Am J Obstet Gynecol. 1965 [acceso 13/10/2020];93:994-1001. Disponible en: https://pubmed.ncbi.nlm.nih.gov/5843414/

  3. Borbón MF, Robles F. Síndrome de Ovario Poliquistico. Rev Clin la Esc Med. 2016 [acceso 13/10/2020];1(I):134-7. Disponible en: https://www.medigraphic.com/pdfs/revcliescmed/ucr-2016/ucr161q.pdf.

  4. Ovies CG, Verdeja VO, Zamora RH. Frecuencia y características clínicas, hormonales y ultrasonográficas sugestivas de síndrome de ovarios poliquísticos en un grupo de mujeres con síndrome metabólico. Rev Cub Endocrinol. 2008 [acceso 13/10/2020];19(1):20-4. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532008000100004

  5. Saucedo de la Llata E, Moraga MR, Romeu A, Carmona R. Proporción LH-FSH y Síndrome de Ovario Poliquístico: ¿Prueba olvidada o no útil? Ginecol Obstet Mex. 2016 [acceso 13/10/2020];84(2):84-94. Disponible en: https://www.medigraphic.com/pdfs/ginobsmex/gom-2016/gom162e.pdf

  6. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004 [acceso 13/10/2020];81(1):19-25. Disponible en: https://pubmed.ncbi.nlm.nih.gov/14711538/

  7. Azziz R, Carmina E, Dewally D. Position Statement: Criteria for defining Polycystic Ovary Syndrome as a predominantly hyperandrogenyc syndrome: An Androgen Excess Society Guideline. J Clin Endocrinol Metab. 2006 [acceso 13/10/2020];91(11):4237-45. Disponible en: https://pubmed.ncbi.nlm.nih.gov/16940456/

  8. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008 [acceso 13/10/2020];23(3):462-77. Disponible en: https://pubmed.ncbi.nlm.nih.gov/1830883/

  9. Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women's health aspects of polycystic ovary syndrome (PCOS). Hum Reprod. 2012 [acceso 13/10/2020];27(1):14-24. Disponible en: https://www.researchgate.net/publication/273217037_Amsterdam_ESHREASRM-Sponsored_3rd_PCOS_Consensus_Worshop_Group_Consensus_on_women%27s_health_aspects_of_polycystic_ovary_syndrome_PCOS

  10. Dewailky D, Luyan M, Carmina E, Cedares M, Laven J, Norman R, et al. Definition and significance of polycysctic ovarian morphology, a task force report from the Androgen excess and Polycystic Ovary Syndrome Society. Hum Reprod. 2014 [acceso 13/10/2020];20(3): 334-52. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24345633/

  11. Schwartzmann L. Calidad de vida relacionada con la salud: aspectos conceptuales. Cienc Enferm. 2003 [acceso 13/10/2020];9(2):9-21. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95532003000200002

  12. WHO. The World Organization quality of life instruments (sf). WHO. 2012 [acceso 13/10/2021] Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662014000200003

  13. Shipper H, Clinch J, Powell V. Definitions and conceptual issues in spiker. Quality of life in assessments in clinical trials New York 1990. Hum Reprod. 2018 [acceso 13/10/2021];34:11-24. Disponible en: https://www.scielo.cl/scielo.php?script=sci_nlinks&ref=7673662&pid=S0717-7526200500020000900010&lng=es.

  14. Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med. 1996 [acceso 13/10/2021];334(13):833-40. Disponible en: https://www.researchgate.net/publication/200051574_Assessment_of_Quality-of-Life_Outcomes

  15. Schumaker S, Elis S, Naughton M. Assissing health-related quality of life in HIV disease: key measurements issues. Qual Life Res. 1997 [acceso 13/10/2021];6(6):475-80. Disponible en: https://pubmed.ncbi.nlm.nih.gov/9330548/

  16. Meeberg GA. Quality of life: a concept analysis. J Advanced Nursing. 1993 [acceso 13/10/2021];18(1):32-8. Disponible en: https://www.semanticscholar.org/paper/Quality-of-Life-in-Contemporary-Nursing-Theory-Plummer-Molzahn/704982d3a386c4c70e2dff16914cc80fd6f7ca71

  17. Nanda U, Andresen E. Health related Quality of life, a guide por the health professional. Eval Health Prof. 1998 [acceso 13/10/2021];21(2):179-215. Disponible en: https://pubmed.ncbi.nlm.nih.gov/10183344/

  18. Beckie TM, Hayduk LA. Measuring quality of life. Social Indicators Research. 1997 [acceso 13/10/2021];42:21-39. Disponible en: https://link.springer.com/article/10.1023/A:1006881931793

  19. Gill TM, Feinstein AR. A critical Appraisal of the quality of life measurements. JAMA. 1994 [acceso 13/10/2021];272(8):619-26. Disponible en: https://pubmed.ncbi.nlm.nih.gov/7726894/

  20. Guyat GH, Feeny DH, Patrick DL. Measuring Health-related quality of life. Annals Inter Med. 1993 [acceso 13/10/2021];18(8):622-9. Dsiponible en: https://pubmed.ncbi.nlm.nih.gov/8452328/

  21. Burke C. Testing an Asthma quality of life model. J Theory Const Testing. 2001 [acceso 13/10/2021];5:38-44. Disponible en: https://www.scielo.cl/scielo.php?script=sci_nlinks&ref=9666936&pid=S0034-9887201300090000600005&lng=es

  22. Haas B. Clarification and integration of similar Quality of life concepts. Image J Nurs Sch 1999 [acceso 13/10/2021];31(3):215-20. Disponible en: https://pubmed.ncbi.nlm.nih.gov/10528449/

  23. Wilson I, Cleary P. Linking clinical variables with health related quality of life. JAMA. 1995 [acceso 13/10/2021];273(1):59-65. Disponible en: https://pubmed.ncbi.nlm.nih.gov/7996652/

  24. Sidra S, Haseeb M, Junaid M, Mohsin M. Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome. PLoS One. 2019 [acceso 13/10/2021];14(10):17. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31603907/

  25. Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian J Psychol Med. 2018 [acceso 13/10/2021];40(3):239-46. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968645/

  26. Stefanaki Ch, Bacopoulou F, Livadas S, Kandaraki A, Karachalios A, Chrousos G, et al. Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial. Stress. 2015 [acceso 13/10/2021];18(1):57–66. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25287137/

  27. Cooney LG, Milman LW, Hantsoo L, Kornfield S, Sammel MD, Allison KC, et al. Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial. Fertil Steril. 2018 [acceso 13/10/2021];110(1):161-72. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29908771/

  28. Cronin L, Guyatt G, Griffith L. Development of Health-related quality of life questionnaire (PCOSQ) for women with Polycystic Ovary Syndrome (PCOS). J Clin Endocrinol Metab. 1998 [acceso 13/10/2021];83(6):5801-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/9626128/

  29. Coffey S, Bano G, Maso HD. Health-related quality of life in polycystic ovary syndrome. a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short From-36 (SF-36). Gynecol Endocrinol. 2006 [acceso 13/10/2021];22(2):80-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/16603432/

  30. Guyatt G, Weaver B, Cronin L, Dooley J, Azziz R. Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. J Clin Epidemiol. 2004 [acceso 13/10/2021];57(12): 1279-87. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15617954/

  31. Jones G, Benes K, Clark T, Denham R, Holder M, Haynes T, et al. The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ): A validation. Hum Reprod. 2004 [acceso 13/10/2021];19(2):371-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/14747184/

  32. Williams S, Sheffield D, Knibb R. The Polycystic Ovary Syndrome Quality of Life scale (PCOSQOL): Development and preliminary validation. Health Psychol Open. 2018 [acceso 13/10/2021];55(2):1–8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053872/

  33. WHO. WHOQOL-BREF Introduction, administration, scoring and version of the assessment. WHO 1996 [acceso 13/10/2021]. Disponible en: https://www.who.int/mental_health/media/en/76.

  34. Trent M, Rich M, Austin B, Gordon C. Quality of Life in Adolescent Girls with Polycystic Ovary Syndrome. Arch Pediatr Adolesc Med. 2002 [acceso 13/10/2021];156(6):556-60. Disponible en: https://pubmed.ncbi.nlm.nih.gov/12038887/

  35. Schmid J, Kirchengast S, Vytiska-Binstorfer E, Huber J. Infertility caused by PCOS-health-related quality of life among Austrian and Moslem immigrant women in Austria. Hum Reprod. 2004 [acceso 13/10/2021];19(10):2251-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15333601/

  36. Rzonca E, Bien A, Wdowiak A, Szymariski R, Iwanowicz P. Determinants of Quality of Life and satifaction with Life in Women with Polycystic Ovary Syndrome. Int J Environ Res Public Health. 2018 [acceso 13/10/2021];15(2):376-85. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29470449/

  37. Basheeruddin SM, Jomah S, Hasan R, Al-Baroudi D, Alharbi M. Impact of polycystic ovary syndrome on eating behavior, depression and health related quality of life: A cross-sectional study in Riyadh. Saudi J Biol Sci. 2020 [acceso 13/10/2021];27(12):3342-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33304140/

  38. Dos S, Rodríguez AM, Martins LB, Franklin MT, Candido AL, Dos Santos L, et al. Poor quality diet is associated with overweight status and obesity in patients with polycistic ovary syndrome. J Hum Nutri Diet. 2015 [acceso 13/10/2021];28(Suppl 2):94-101. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24479991/

  39. Gueck C, Goldenbeng N. Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metabolic. 2019 [acceso 13/10/2021];92:108-20. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30445140/

  40. Mohd M, Maqboo M, Amin M, Mushtaq I. Polycystic Ovary Syndrome, a modern epidemic: An overview. J Drug Delivery Therap. 2019 [acceso 13/10/2021];9(3):641-4. Disponible en: http://jddtonline.info/index.php/jddt/article/view/2661

  41. Barber TM, Hanson P, Weickert MO, Franks S. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies. Clin Med Insigt Reprod Health. 2019 [acceso 13/10/2021];13:1–9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734597/

  42. Elsenbruch S, Hahn S, Kowalsky D, Öffner A, Schedlowski M, Mann K. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003 [acceso 13/10/2021];88(12):5801-7. Disponible en: https://academic.oup.com/jcem/article/88/12/5801/2661484

  43. Hahn S, Janssen O, Tan S, Pleger K ,Mann K, Schedlowski M. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrine. 2005 [acceso 13/10/2021];153(6);853-60. Disponible en: https://pubmed.ncbi.nlm.nih.gov/16322391/

  44. Scaruffi E, Gambineri A, Cattaneo S, Turra J, Vettor R, Mioni R. Personality and psychiatric disorders in women affected by polycystic ovary syndrome. Front Endocrinol. 2014 [acceso 13/10/2021];5:185-93. Disponible en: https://www.frontiersin.org/articles/10.3389/fendo.2014.00185/full

  45. Hung JH, Hu LY, Tsai SJ, Yang AC, Huang MW, Chen PM, et al. Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study. PLoS One. 2014 [acceso 13/10/2021];9(5):1-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24816764/

  46. Panico A, Messina G, Lupoli G, Lupoli R, Carcuapuoti M, Mosceteli F, et al. Quality of life in overweight (obese) and normal-weight women with polycys-tic ovary syndrome. Patient Prefer Adherence. 2017 [acceso 13/10/2021];11:423-9. Disponible en: https://www.revistas.una.ac.cr/index.php/mhsalud/article/view/9073

  47. Dokras A, Stener-Victorin E, Yildiz BO, Li R, Ottey S. Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril. 2018 [acceso 13/10/2021];109(5):88-99. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29778388/

  48. Kaczmarek C, Haller DM, Yaron M. Health related quality of life in adolescents and young adults with polycystic ovary syndrome: A systematic review. J Ped Adolest Gynecol. 2016 [acceso 13/10/2021];29(6):551-7. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364602/

  49. Ovies G, Pérez A, Domínguez E. Calidad de vida en mujeres con síndrome de ovario poliquístico. [Tesis de grado]. La Habana; Universidad de Ciencias Médicas de La Habana; 2020.

  50. Vázquez JC, Calero JL, Carias P, Monteagudo G. Correspondencia clínica, hormonal y ecográfica en el diagnóstico del síndrome de ovarios poliquístico. Rev Cub Endocrinol. 2016 [acceso 13/10/2021];27(1):4-17. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532016000100002

  51. Bazarganipour F, Taghavi SA, Montazeri A, Ahmadi F, Chaman R, Khosravi A. The impact of polycystic ovary syndrome on the health-related quality of life: A systematic review and meta-analysis. Iran J Reprod Med. 2015 [acceso 13/10/2021];13(2):61-70. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426142/

  52. Coffey S, Mason H. The Effect of Polycystic Ovary Syndrome on Health-Related Quality of Life. Gynecol Endocrinol. 2003 [acceso 13/10/2021];17(5):379-86. Disponible en: https://pubmed.ncbi.nlm.nih.gov/14710585/

  53. Keegan A, Liao LM, Boyile M. Hirsutism: A psychological analysis. J Health Psychol. 2003 [acceso 13/10/2021];8(3):327-45. Disponible en: https://pubmed.ncbi.nlm.nih.gov/14670212/

  54. Bazanganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, Faghihzadeh S. Psychological investigation in patients with polycystic ovary syndrome. Health Qual Life Outcomes. 2013 [acceso 13/10/2021];11:8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/23947827/

  55. Borghi L, Leone D, Vegni E, Galiano V, Lepadatu C, Sulpizio P, et al. Psychological distress, anger and quality of life in polycystic ovary syndrome: associations with biochemical, phenotypical and socio-demographic factors. J Psych Obst Gynecol. 2017 [acceso 13/10/2021];39(2):128-37. Disponible en: https://www.bibliomed.org/fulltextpdf.php?mno=290378

  56. Brassard M, Ainmelk Y, Baillargeon JP. Basic infertility including polycystic ovary syndrome. Med Clin North Am. 2008 [acceso 13/10/2021];92(5):1163–92. Disponible en: https://pubmed.ncbi.nlm.nih.gov/18721657/

  57. Tan S, Hahn S, Benson S, Janssen OE, Dietz O, Kimmig R, et al. Psychological implications of infertility in women with polycystic ovary syndrome. Hum Reprod. 2008 [acceso 13/10/2021];23(9):2064-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/18583330/

  58. Brady C, Mousa SS, Mousa SA. Polycystic ovary syndrome and its impact on women´s quality of life: More than an endocrine disorder. Drug Healthc Patient Saf. 2009 [acceso 13/10/2021];1:9-15. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21701605/

  59. Muñoz L, Villa L, Araya A, Urrutia M. Calidad de vida en mujeres con síndrome de ovario poliquístlco. Horiz Enferm. 2010 [acceso 13/10/2021];21(1):11-8. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262005000200009

  60. Trent M, Rich M, Austin B, Gordon C. Fertility concerns and sexual behaviors in adolescents girls with polycystic ovary syndrome: implications for quality of life. J Pediatr Adolesc Gynecol. 2003 [acceso 13/10/2021];16(1):33-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/12604144/

  61. Dokras A, Stener-Victorin E, Yildiz BO, Li R, Ottey S. Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril. 2018 [acceso 13/10/2021];109(5):888-99. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29778388/

  62. Nunes Rd, Santos IK, Cobucci RN, Pichini GS, Soares GM, Maranhão TM, et al. Lifestyle interventions and quality of life for women with polycystic ovary syndrome: a systematic review and meta-analysis protocol. Medicine. 2019 [acceso 13/10/2021];98:6. Disponible en: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-017-0666-5

  63. Naumova I, Castelo-Branco C, Kasterina I. Quality of Life in Infertile Women with Polycystic Ovary Syndrome: a Comparative Study. Reprod Sci. 2020 [acceso 13/10/2021];28(7):1901–9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33215316/

  64. Syeda S, Muhammad H, Muhammad J, Muhammad M. Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary síndrome. PLoS One. 2019 [acceso 13/10/2021];14(10):17. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31603907/

  65. Amiri M, Bidhendi Y, Nahidi F, Tohidi M, Ramezani F. The relationship between clinical and biochemical characteristics and quality of life in patients with polycystic ovary syndrome. Clin Endocrinol. 2019 [acceso 13/10/2021];90(1): 129-37. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30229992/

  66. Sánchez ML, Adoamnei E, Prieto MT, Mendiola J, Corbalán S. Health-related quality of life in women with polycystic ovary syndrome attending to a tertiary hospital in Southeastern Spain: a case-control study. Health Qual Life Outcomes. 2020 [acceso 13/10/2021];18(1):10. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911683/

  67. Benhboodi Z, Fereidonni B, Saffori M, Montazen A. Measures of health-related quality of life in PCOS women: a systematic review. Int J Womens Health. 2018 [acceso 13/10/2021];10:397-408. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30123008/

  68. Huang HT, Chen PC, Wu MH, Lin CY. Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome. Health Qual Life Outcomes. 2016 [acceso 13/10/2021];14(1):10. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995650/

  69. Clayton WJ, Lipton M, Elford J, Rustin M, Sherr L. A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol. 2005 [acceso 13/10/2021];152(5):986–92. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15888157/

  70. Amiri M, Nahidi F, Yarandi RB, Khalili D, Tohidi M, Tehrani FR. Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial. Health Qual of Life Outcomes. 2020 [acceso 13/10/2021];18:12. Disponible en: https://hqlo.biomedcentral.com/articles/10.1186/s12955-020-01544-4




2020     |     www.medigraphic.com